List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 8 studies with search of: "Lenograstim"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Bortezomib Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Every 2 Weeks for Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL)
Conditions: Lymphoma, Large-Cell, Diffuse;   Lymphoma, B-Cell
Interventions: Drug: Bortezomib;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisolone;   Drug: Lenograstim
2 Recruiting Sitagliptin Plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction
Condition: Acute Myocardial Infarction
Interventions: Drug: Lenograstim (GRANOCYTE)=GCSF;   Drug: Sitagliptin (Januvia);   Drug: Sodium Chloride (NaCl) 0.9 %;   Drug: Gelatin
3 Recruiting Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
Conditions: Diffuse Large B-Cell Lymphoma;   IPI≥2
Interventions: Drug: Rituximab;   Drug: Ciclofosfamide;   Drug: Doxorubicina;   Drug: Vincristina;   Drug: Prednisone;   Drug: Pegfilgrastim;   Drug: Mitoxantrone;   Drug: ARA-C;   Drug: Lenograstim;   Drug: BCNU;   Drug: ARA-C;   Drug: VP-16;   Procedure: ASCT;   Drug: Ciclofosfamide;   Drug: Doxorubicina;   Drug: Vincristina
4 Recruiting Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
Conditions: Brain and Central Nervous System Tumors;   Extragonadal Germ Cell Tumor;   Ovarian Cancer;   Testicular Germ Cell Tumor
Interventions: Biological: filgrastim;   Biological: lenograstim;   Biological: pegfilgrastim;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: ifosfamide;   Drug: paclitaxel
5 Completed Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)
Condition: Myocardial Infarction
Interventions: Drug: G-CSF Granulocyte-Colony Stimulating Factor;   Other: Placebo
6 Recruiting Six vs 12 Months of Transtuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Trastuzumab;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: 5-fluoruracil;   Drug: Granulocyte-colony stimulating growth factor;   Drug: Trastuzumab
7 Completed Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Paclitaxel;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: 5-fluoruracil;   Drug: Granulocyte-colony stimulating growth factor
8 Active, not recruiting Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: isolated perfusion;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services